Commercially Available Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Another Piece in Our Tool Box, but Not a Swiss Army Knife Yet

Circ Cardiovasc Genet. 2017 Oct;10(5):e001913. doi: 10.1161/CIRCGENETICS.117.001913.

Authors

Leif-Hendrik Boldt¹, Abdul S Parwani², Frank R Heinzel²

Affiliations

¹ From the Department of Cardiology, Charité - Universitätsmedizin Berlin, Germany; and DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany (L.H.B., F.R.H.). leif-hendrik.boldt@charite.de.
² From the Department of Cardiology, Charité - Universitätsmedizin Berlin, Germany; and DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany (L.H.B., F.R.H.).

PMID: 29021307
DOI: 10.1161/CIRCGENETICS.117.001913

No abstract available

Keywords: Andersen syndrome; Editorials; atrial fibrillation; cardiomyocytes; pluripotent stem cell; stem cell.

Publication types

Editorial
Comment

MeSH terms

Cell Differentiation
Humans
Induced Pluripotent Stem Cells*
Mutation
Myocytes, Cardiac
Pluripotent Stem Cells*
Potassium Channels, Inwardly Rectifying*
Virulence

Substances

KCNJ2 protein, human
Potassium Channels, Inwardly Rectifying